Toggle navigation
PDFSEARCH.IO
Document Search Engine - browse more than 18 million documents
Sign up
Sign in
Back to Results
First Page
Meta Content
View Document Preview and Link
August I,[removed]IMPORTANT PRESCRIBING INFORMATION / RE: Revised prescribin,0 information regarding the preferred twice-daily dosing for VIDEX@ (didanosine) based on new study results Dear Healthcare Provider,
Add to Reading List
Open Document
File Size: 65,92 KB
Share Result on Facebook
Company
Dear Healthcare Provider /
Bristol-Myers Squibb Company /
Therefore /
/
IndustryTerm
treatment of HIV /
/
MedicalCondition
HIV-I infection /
HIV RNA /
HIV-RNA ~400 /
/
Organization
VIDEX@ administration /
/
Product
didanosine /
zidovudine /
VIDEX /
lamivudine /
stavudine /
/
SocialTag
Purines
Pharmacology
Organofluorides
Didanosine
Reverse-transcriptase inhibitor
Antiretroviral drug
Protease inhibitors
Nucleoside analogue
Lamivudine
Bristol-Myers Squibb